Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending September 24, 2021

Overall drug TRx are -0.4% w/w

Vascepa
TRx 82,667; +0.7% (+568) w/w; -11.3% y/y
NRx 37,394; +0.7% (+274) w/w; -14.8% y/y
Ref 45,273; +0.7% (+294) w/w; -8.3% y/y

Lovaza (Generic & Brand)
TRx 64,191; -0.1% (-75) w/w; -0.8% y/y
NRx 31,167; -0.8% (-240) w/w; -4.9% y/y
Ref 33,024; +0.5% (+165) w/w; +3.4% y/y

Generic Vascepa
TRx 19,143; -0.6% (-120) w/w; As % of total V: 18.8%
NRx 10,757; -0.8% (-84) w/w; As % of total V: 22.3%
Ref 8,386; -0.4% (-36) w/w; As % of total V: 15.6%

Generic Vascepa by Manufacturer
Hikma - TRx 12,753 (-81); Generic share 66.6%; Total V share 12.5%
Reddy - TRx 6,391 (-39); Generic share 33.4%; Total V share 6.3%

TRx Vascepa + Generic Vascepa: 101,810 (+447)